Kyra van der Pan,Sandra de Bruin-Versteeg,Daniela Damasceno,Alejandro Hernández-Delgado,Alita J. van der Sluijs-Gelling,Wouter B. L. van den Bossche,Inge F. de Laat,Paula Díez,Brigitta A. E. Naber,Annieck M. Diks,Magdalena A. Berkowska,Bas de Mooij,Rick J. Groenland,Fenna J. de Bie,Indu Khatri,Sara Kassem,Anniek L. de Jager,Alesha Louis,Julia Almeida,Jacqueline A. M. van Gaans-van den Brink,Alex-Mikael Barkoff,Qiushui He,Gerben Ferwerda,Pauline Versteegen,Guy A. M. Berbers,Alberto Orfao,Jacques J. M. van Dongen,Cristina Teodosio

Abstract:Innate myeloid cell (IMC) populations form an essential part of innate immunity. Flow cytometric (FCM) monitoring of IMCs in peripheral blood (PB) has great clinical potential for disease monitoring due to their role in maintenance of tissue homeostasis and ability to sense micro-environmental changes, such as inflammatory processes and tissue damage. However, the lack of standardized and validated approaches has hampered broad clinical implementation. For accurate identification and separation of IMC populations, 62 antibodies against 44 different proteins were evaluated. In multiple rounds of EuroFlow-based design-testing-evaluation-redesign, finally 16 antibodies were selected for their non-redundancy and separation power. Accordingly, two antibody combinations were designed for fast, sensitive, and reproducible FCM monitoring of IMC populations in PB in clinical settings (11-color; 13 antibodies) and translational research (14-color; 16 antibodies). Performance of pre-analytical and analytical variables among different instruments, together with optimized post-analytical data analysis and reference values were assessed. Overall, 265 blood samples were used for design and validation of the antibody combinations and in vitro functional assays, as well as for assessing the impact of sample preparation procedures and conditions. The two (11- and 14-color) antibody combinations allowed for robust and sensitive detection of 19 and 23 IMC populations, respectively. Highly reproducible identification and enumeration of IMC populations was achieved, independently of anticoagulant, type of FCM instrument and center, particularly when database/software-guided automated ( vs. manual “expert-based”) gating was used. Whereas no significant changes were observed in identification of IMC populations for up to 24h delayed sample processing, a significant impact was observed in their absolute counts after >12h delay. Therefore, accurate identification and quantitation of IMC populations requires sample processing on the same day. Significantly different counts were observed in PB for multiple IMC populations according to age and sex. Consequently, PB samples from 116 healthy donors (8-69 years) were used for collecting age and sex related reference values for all IMC populations. In summary, the two antibody combinations and FCM approach allow for rapid, standardized, automated and reproducible identification of 19 and 23 IMC populations in PB, suited for monitoring of innate immune responses in clinical and translational research settings.

Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry

Design of a Robust Flow Cytometric Approach for Phenotypical and Functional Analysis of Human Monocyte Subsets in Health and Disease

[Flow cytometry in chronic lymphproliferative disorders: report of a survey on practices on behalf of CytHem].

Flow cytometry analysis of unusual peripheral monocyte population

Identification of Novel Human Monocyte Subsets and Evidence for Phenotypic Groups Defined by Interindividual Variations of Expression of Adhesion Molecules

Blood Monocytes and Their Subsets: Established Features and Open Questions

Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia

Comprehensive analysis of human monocyte subsets using full-spectrum flow cytometry and hierarchical marker clustering

High-Content Immunophenotyping and Hierarchical Clustering Reveal Sources of Heterogeneity and New Surface Markers of Human Blood Monocyte Subsets

[Role of Flow Cytometry in the Diagnosis of Chronic Myeloid Leukemia].

Can Immature Granulocyte Counting be Utilized in the Selection of Samples for Flow Cytometric Enumeration of Stem Cells?

Elimination of erroneous results in flow cytometry caused by antibody binding to Fc receptors on human monocytes and macrophages

Automated EuroFlow approach for standardized in-depth dissection of human circulating B-cells and plasma cells

Quantitative Magnetic Flow Cytometry in High Hematocrit Conditions for Point-of-Care Testing

Clinical significance of monocyte heterogeneity

Discrepant Phenotyping of Monocytes Based on CX3CR1 and CCR2 Using Fluorescent Reporters and Antibodies

Diagnosis of chronic B‐cell lymphoproliferative disease in peripheral blood = how machine learning may help to the interpretation of flow cytometry data

A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients

Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood

Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes

Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis